Radiomics AI prediction for head and neck squamous cell carcinoma (HNSCC) prognosis and recurrence with target volume approach
BJR|Open · 14.05.2021 · 3 (1)
DOI: 10.1259/bjro.20200073 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJR|Open, online erschienen am 28.05.2021. Verfasst von Tang Fh und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Health Sciences, Tung Wah College, Hong Kong, Hong Kong. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the performance of radiomics features extracted from planning target volume (PTV) and gross tumor volume (GTV) in the prediction of the death prognosis and cancer recurrence rate for head and neck squamous cell carcinoma (HNSCC).
Methods
188 HNSCC patients’ planning CT images with radiotherapy structures sets were acquired from Cancer Imaging Archive (TCIA). The 3D slicer (v. 4.10.2) with the PyRadiomics extension (Computational Imaging and Bioinformatics Lab, Harvard medical School) was used to extract radiomics features from the radiotherapy planning images. An in-house developed deep learning artificial neural networks (DL-ANN) model was used to predict death prognosis and cancer recurrence rate based on the features extracted from GTV and PTV of the CT images.
Results
The PTV radiomics features with DL-ANN model could achieve 77.7% accuracy with overall AUC equal to 0.934 and 0.932 when predicting HNSCC-related death prognosis and cancer recurrence respectively. Furthermore, the DL-ANN model can achieve an accuracy of 74.3% with AUC equal to 0.947 and 0.956 for the HNSCC-related death prognosis and cancer recurrence respectively using GTV features.
Conclusion
Using both GTV and PTV radiomics features in the DL-ANN model, can aid in predicting HNSCC-related death prognosis and cancer recurrence. Clinicians may find it helpful in formulating different treatment regimens and facilitate personized medicine based on the predicted outcome when performing GTV and PTV delineation. Advances in knowledge: Radiomics features of GTV and PTV are reliable prognosis and recurrence predicting tools, which may help clinicians in GTV and PTV delineation to facilitate delivery of personalized treatment.
Autor:innen und Institutionen
- School of Medical and Health Sciences, Tung Wah College, Hong Kong, Hong Kong.
Zitieren
APA
Fh, T., Cyw, C., & Eyw, C. (2021). Radiomics AI prediction for head and neck squamous cell carcinoma (HNSCC) prognosis and recurrence with target volume approach. BJR|Open, 3(1). https://doi.org/10.1259/bjro.20200073
Vancouver
Fh T, Cyw C, Eyw C. Radiomics AI prediction for head and neck squamous cell carcinoma (HNSCC) prognosis and recurrence with target volume approach. BJR|Open. 2021;3(1). doi:10.1259/bjro.20200073
BibTeX
@article{Fh2021,
author = {Fh, Tang and Cyw, Chu and Eyw, Cheung},
title = {Radiomics AI prediction for head and neck squamous cell carcinoma (HNSCC) prognosis and recurrence with target volume approach},
journal = {BJR|Open},
year = {2021},
volume = {3},
number = {1},
doi = {10.1259/bjro.20200073}
}
EUVIMED